Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Artificial intelligence (AI) Task Force

Artificial intelligence (AI) Task Force

BACK

Artificial intelligence (AI) Task Force

Mission: Engage in all AA activities related to AI

AI can be a powerful tool to support evidence-based policymaking in the healthcare sector, leading to more efficient, effective, and equitable health policies.
By incorporating novel AI techniques into in-silico models, researchers can gain deeper insights into biological processes, drug interactions, disease mechanisms, and patient responses to treatments.

Reciprocally, the European Commission’s creation of the European Health Data Space and the proposed AI legislation will have an important impact on the further development of not only data-driven models but of in-silico medicine as a whole.

Through the Avicenna Alliance and in collaboration with the R&T WG, the AI TF is driving efforts to establish the AA as an ideal partner for the EC, FDA and other stakeholders and collaborate with other relevant consortia on AI and Digital Twins.

Other goals of this TF include to contribute to development of relevant standards, identify useful data to promote specific AI technologies, collect and show success case studies, provide input on AI-related policy questions, and increase awareness on the adoption of AI within the AA.

Goals

  • Establish the AA as an ideal partner for the EC, FDA and other stakeholders
  • Presence of the combination of application-specific knowledge and technical background
  • Identify useful data to promote specific AI technologies
  • Collect and show success case studies 4.Provide input on AI-related policy questions

Gemma Piella

Gemma Piella

Co-Chair of the Artificial Intelligence (AI) Task Force

Full Professor, University of Pompeu Fabra (UPF)

READ BIO

NEWS

News The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

The European Parliament voted the reform of General Pharmaceutical Legislation (GPL)

On April 10, the European Parliament overwhelmingly backed the reform of General Pharmaceutical Legislation (GPL), marking a pivotal moment in healthcare regulation. With a resounding majority, both the Directive and Regulation were embraced, reflecting a collaborative effort within the ENVI committee.

News The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

The Avicenna Alliance warmly welcomes Tox By Design into its esteemed ranks!

Tox by Design is a prominent European toxicological expertise firm specializing in conducting toxicological Risk Assessments (RAs) for various industries such as biotech, pharmaceuticals, cosmetics, medical devices, and API synthesis.

News Marc Horner is the new Avicenna International Affairs Working Group Leader

Marc Horner is the new Avicenna International Affairs Working Group Leader

We are thrilled to announce that Marc Horner, Distinguished Engineer at Ansys, and Global Harmonization Task Force leader at the Avicenna Alliance, has been appointed as the new International Affairs Working Group Leader. Marc was already acting as a close partner of Nathalie Virag, former head of the International Affairs Working Group, recently appointed by Medtronic to prestigious responsibilities.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry